Application 088252
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEXAMETHASONE INTENSOL | DEXAMETHASONE | CONCENTRATE;ORAL | 1MG/ML | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088252-001 | DEXAMETHASONE INTENSOL | DEXAMETHASONE | 1MG/ML | CONCENTRATE / ORAL | RLD, RS | 1983-09-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A088252-001 | DEXAMETHASONE INTENSOL | 1MG/ML | CONCENTRATE / ORAL | RS | 1983-09-01 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A088252-001 | DEXAMETHASONE INTENSOL | 1MG/ML | CONCENTRATE / ORAL | RS | 1983-09-01 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A088252-001 | DEXAMETHASONE INTENSOL | 1MG/ML | CONCENTRATE / ORAL | RS | 1983-09-01 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A088252-001 | DEXAMETHASONE INTENSOL | 1MG/ML | CONCENTRATE / ORAL | RLD, RS | 1983-09-01 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone Intensol | DEXAMETHASONE INTENSOL | Sportpharm LLC | 77429dd3-e66d-4ab4-a3f3-5ae0b987ac17 | 2026-08-21 | Warnings, Adverse reactions | 088252 ANDA088252 |
| Dexamethasone Intensol | DEXAMETHASONE INTENSOL | Hikma Pharmaceuticals USA, Inc. | b15200fb-1826-472b-a907-e677a272513b | 2025-06-06 | Warnings, Adverse reactions | 088252 ANDA088252 0054-3176 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0054-3176 | Dexamethasone Intensol | Dexamethasone Intensol | West-Ward Pharmaceuticals Corp. | ANDA | Current |
| 0054-3176 | Dexamethasone Intensol | Dexamethasone Intensol | West-Ward Pharmaceuticals Corp. | ANDA | Current |
| 0054-3176 | Dexamethasone Intensol | Dexamethasone Intensol | West-Ward Pharmaceuticals Corp. | ANDA | Current |
| 0054-3176 | Dexamethasone Intensol | Dexamethasone Intensol | Hikma Pharmaceuticals USA, Inc. | ANDA | Current |
| 68151-5026 | Dexamethasone Intensol | Dexamethasone Intensol | Carilion Materials Management | ANDA | Current |